Cardiac HealthNCT01474577
Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging
An observational study of Cardiac Health, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
Trial summary
The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future? Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Cardiac Health
- What is being tested?
- questionnaire
- How many people
- 57 participants
- Where
- 1 siteUnited States
- Study dates
- 8 Nov 2011to 18 May 2017
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008-2011.
Who may be able to join
- Patient > or = to 18 years of age
- Registered patient at MSKCC
- Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008-2011
Who cannot join
- Patient is unwilling to participate
Trial locations and contacts
1 site in 1 country.
United States1 site
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065
About this study
The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?
- Conditions
- Cardiac Health
- Being tested
- questionnaire
- Keywords
- stress test, cardiac issues, Rb-82 PET Myocardial Perfusion Imaging, 11-150, one or more 82Rb myocardial perfusion stress tests
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
questionnaireOther
Patients will complete one questionnaire over the phone. We will ask patients to describe their cardiac history since Rb-82 PET (chest pain, shortness of breath, cardiac catheterization, and heart attack). This information will be correlated to the scan results and other relevant information in the patient's medical record.
| Study group | Role | What they receive |
|---|---|---|
| pts who have had Rb-82 PET myocardial perfusion imaging | Eligible patients will have had Rb-82 PET myocardial perfusion imaging at MSKCC, 2008 - 2011. Patients will complete one questionnaire over the phone. Receives: Other: questionnaire |
What is being measured
The primary outcome is the main question the study is designed to answer.
correlate scan findings with clinical outcomes
Patients will complete one questionnaire over the phone.
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 Nov 2011 (estimated)
- Study start8 Nov 2011
- Primary completion18 May 2017
- Study completion18 May 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cardiac HealthStudies of the same condition, open and under way.
- More trials run by Memorial Sloan Kettering Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 57 participants (actual)
Sponsor and investigators
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Heiko Schöder, MD, Principal investigator, Memorial Sloan Kettering Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01474577
- Sponsor's protocol ID
- 11-150
- Status last verified
- Nov 2016
- First submitted
- 15 Nov 2011
- Last updated
- 9 Apr 2018
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Apr 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging
- ClinicalTrials.gov ID
- NCT01474577
- Acronym / sponsor ID
- 11-150
- Conditions
- Cardiac Health
- Keywords
- stress test, cardiac issues, Rb-82 PET Myocardial Perfusion Imaging, 11-150, one or more 82Rb myocardial perfusion stress tests
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 57 participants (actual)
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterUniversity, hospital or other
- Study start
- 8 Nov 2011 (actual)
- Primary completion
- 18 May 2017 (actual)
- Study completion
- 18 May 2017 (actual)
- First posted
- 18 Nov 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| pts who have had Rb-82 PET myocardial perfusion imaging | – | Other: questionnaireEligible patients will have had Rb-82 PET myocardial perfusion imaging at MSKCC, 2008 - 2011. Patients will complete one questionnaire over the phone. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008-2011.
Key inclusion criteria (3 listed)
- Patient > or = to 18 years of age
- Registered patient at MSKCC
- Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008-2011
Key exclusion criteria (1 listed)
- Patient is unwilling to participate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| questionnairePatients will complete one questionnaire over the phone. We will ask patients to describe their cardiac history since Rb-82 PET (chest pain, shortness of breath, cardiac catheterization, and heart attack). This information will be correlated to the scan results and other relevant information in the patient's medical record. | Other | pts who have had Rb-82 PET myocardial perfusion imaging |
Primary outcome
correlate scan findings with clinical outcomes
Time frame: 1 year
Patients will complete one questionnaire over the phone.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Apr 2018.
- Memorial Sloan-Kettering Cancer CenterLink provided by the sponsor.
Related trials for Cardiac Health
Not yet recruiting
Effect of Stress Ball Use During Femoral Arterial Sheath Removal After Coronary Angiography
Femoral Arterial Sheath Removal, Stress Ball
Enrolling by invitationObservational study
Multi-Scale Analysis of Phenotypes in Heart Failure (MAP-HEART)
Heart Failure
Recruiting
Exercise to Improve Heart and Metabolic Health After Childbirth in Women at High Risk for Preeclampsia
Postpartum Exercise, Cardiometabolic Health
Not yet recruitingPhase 3
MUTTON-HF Pilot Expansion
Heart Failure
Active, not recruiting
NYUCI-ES: Psychosocial Intervention to Improve Health Outcomes for Chinese and Korean ADRD Caregivers
Dementia Caregivers, Diabetes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Heiko Schöder, MD principal investigator
Memorial Sloan Kettering Cancer Center
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiac Health, run by Memorial Sloan Kettering Cancer Center at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Apr 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
correlate scan findings with clinical outcomes (time frame: 1 year). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2018.